308 related articles for article (PubMed ID: 22112846)
1. Study of the cytotoxicity and particle action in human cancer cells of titanocene-functionalized materials with potential application against tumors.
García-Peñas A; Gómez-Ruiz S; Pérez-Quintanilla D; Paschke R; Sierra I; Prashar S; del Hierro I; Kaluđerović GN
J Inorg Biochem; 2012 Jan; 106(1):100-10. PubMed ID: 22112846
[TBL] [Abstract][Full Text] [Related]
2. Improvement of cytotoxicity of titanocene-functionalized mesoporous materials by the increase of the titanium content.
Kaluderović GN; Pérez-Quintanilla D; Zizak Z; Juranić ZD; Gómez-Ruiz S
Dalton Trans; 2010 Mar; 39(10):2597-608. PubMed ID: 20179853
[TBL] [Abstract][Full Text] [Related]
3. A new generation of anticancer drugs: mesoporous materials modified with titanocene complexes.
Pérez-Quintanilla D; Gómez-Ruiz S; Zizak Z; Sierra I; Prashar S; del Hierro I; Fajardo M; Juranić ZD; Kaluderović GN
Chemistry; 2009; 15(22):5588-97. PubMed ID: 19370742
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs.
Gómez-Ruiz S; Kaluderović GN; Prashar S; Polo-Cerón D; Fajardo M; Zizak Z; Sabo TJ; Juranić ZD
J Inorg Biochem; 2008 Aug; 102(8):1558-70. PubMed ID: 18353439
[TBL] [Abstract][Full Text] [Related]
5. Multinuclear cytotoxic metallodrugs: physicochemical characterization and biological properties of novel heteronuclear gold-titanium complexes.
Wenzel M; Bertrand B; Eymin MJ; Comte V; Harvey JA; Richard P; Groessl M; Zava O; Amrouche H; Harvey PD; Le Gendre P; Picquet M; Casini A
Inorg Chem; 2011 Oct; 50(19):9472-80. PubMed ID: 21875041
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer applications of titanocene-functionalised nanostructured systems: an insight into cell death mechanisms.
Ceballos-Torres J; Virag P; Cenariu M; Prashar S; Fajardo M; Fischer-Fodor E; Gómez-Ruiz S
Chemistry; 2014 Aug; 20(34):10811-28. PubMed ID: 24715574
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
8. Anticancer activity of dinuclear gallium(III) carboxylate complexes.
Kaluderović MR; Gómez-Ruiz S; Gallego B; Hey-Hawkins E; Paschke R; Kaluderović GN
Eur J Med Chem; 2010 Feb; 45(2):519-25. PubMed ID: 19926362
[TBL] [Abstract][Full Text] [Related]
9. Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes.
Liu Z; Salassa L; Habtemariam A; Pizarro AM; Clarkson GJ; Sadler PJ
Inorg Chem; 2011 Jun; 50(12):5777-83. PubMed ID: 21618978
[TBL] [Abstract][Full Text] [Related]
10. Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.
Peri D; Meker S; Manna CM; Tshuva EY
Inorg Chem; 2011 Feb; 50(3):1030-8. PubMed ID: 21214265
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the cytotoxicity of titanocene dichloride by aging in organic co-solvent.
Ravera M; Cassino C; Monti E; Gariboldi M; Osella D
J Inorg Biochem; 2005 Dec; 99(12):2264-9. PubMed ID: 16209887
[TBL] [Abstract][Full Text] [Related]
12. Preliminary study of the anticancer applications of mesoporous materials functionalized with the natural product betulinic acid.
Sánchez-Muñoz S; Gómez-Ruiz S; Pérez-Quintanilla D; Morante-Zarcero S; Sierra I; Prashar S; Paschke R; Kaluđerović GN
ChemMedChem; 2012 Apr; 7(4):670-9. PubMed ID: 22278996
[TBL] [Abstract][Full Text] [Related]
13. Trans titanium(IV) complexes of salen ligands exhibit high antitumor activity.
Tzubery A; Tshuva EY
Inorg Chem; 2011 Sep; 50(17):7946-8. PubMed ID: 21797239
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.
Gao E; Liu L; Zhu M; Huang Y; Guan F; Gao X; Zhang M; Wang L; Zhang W; Sun Y
Inorg Chem; 2011 Jun; 50(11):4732-41. PubMed ID: 21520903
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.
Ludwig G; Mijatović S; Ranđelović I; Bulatović M; Miljković D; Maksimović-Ivanić D; Korb M; Lang H; Steinborn D; Kaluđerović GN
Eur J Med Chem; 2013 Nov; 69():216-22. PubMed ID: 24042044
[TBL] [Abstract][Full Text] [Related]
16. Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.
Pelletier F; Comte V; Massard A; Wenzel M; Toulot S; Richard P; Picquet M; Le Gendre P; Zava O; Edafe F; Casini A; Dyson PJ
J Med Chem; 2010 Oct; 53(19):6923-33. PubMed ID: 20822096
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.
Primik MF; Göschl S; Jakupec MA; Roller A; Keppler BK; Arion VB
Inorg Chem; 2010 Dec; 49(23):11084-95. PubMed ID: 20979395
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity of mesoporous silica nanomaterials.
Di Pasqua AJ; Sharma KK; Shi YL; Toms BB; Ouellette W; Dabrowiak JC; Asefa T
J Inorg Biochem; 2008 Jul; 102(7):1416-23. PubMed ID: 18279965
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic salan-titanium(IV) complexes: high activity toward a range of sensitive and drug-resistant cell lines, and mechanistic insights.
Manna CM; Braitbard O; Weiss E; Hochman J; Tshuva EY
ChemMedChem; 2012 Apr; 7(4):703-8. PubMed ID: 22262543
[TBL] [Abstract][Full Text] [Related]
20. Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells.
O'Connor K; Gill C; Tacke M; Rehmann FJ; Strohfeldt K; Sweeney N; Fitzpatrick JM; Watson RW
Apoptosis; 2006 Jul; 11(7):1205-14. PubMed ID: 16699961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
